In a recent study, patients of all age categories were less likely to conceive if they had low antimüllerian hormone levels, highlighting its potential in reproductive counseling.

In a recent study, an inverse relationship was discovered between anti-Müllerian hormone levels and early menopause, highlighting the need to develop interventions for fertility preservation based on genetics.

In a recent study, endometriosis-associated pain was reduced among patients taking elagolix, with bone mineral density mitigated using add-back therapy.

In a recent study, the prevalence of gynecological cancer trials was reduced in states with high economic vulnerability and minoritized populations.